Literature DB >> 8743482

Vasopressin receptors in health and disease.

D G Bichet1.   

Abstract

The molecular cloning and characterization of receptors for the nonapeptide hormone family vasopressin-oxytocin was rapidly followed by the identification of mutations in the V2 receptor gene segregating with the clinical phenotype in more than a hundred families with X-linked nephrogenic diabetes insipidus. Together with the recent cloning of the vasopressin-regulated water channel in the apical membrane of the collecting duct tubule and of the identification of rare autosomal recessive nephrogenic diabetes insipidus patients with mutations in the AQP2 gene, these developments enable carrier detection and early diagnosis of infants with congenital nephrogenic diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743482     DOI: 10.1038/ki.1996.252

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

2.  Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.

Authors:  V Kirchlechner; D Y Koller; R Seidl; F Waldhauser
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 3.  Cell culture models and animal models for studying the patho-physiological role of renal aquaporins.

Authors:  G Tamma; G Procino; M Svelto; G Valenti
Journal:  Cell Mol Life Sci       Date:  2011-12-22       Impact factor: 9.261

Review 4.  The Biology of Vasopressin.

Authors:  Samantha Sparapani; Cassandra Millet-Boureima; Joshua Oliver; Kathy Mu; Pegah Hadavi; Tamar Kalostian; Nazifa Ali; Carla Maria Avelar; Marion Bardies; Brenton Barrow; Minky Benedikt; Giuliana Biancardi; Raminder Bindra; Lisa Bui; Zakaria Chihab; Ashley Cossitt; Jeffrey Costa; Tina Daigneault; Jocelyn Dault; Isa Davidson; Jonathan Dias; Emie Dufour; Sabine El-Khoury; Nargess Farhangdoost; Anika Forget; Alexa Fox; Myriam Gebrael; Maria Concetta Gentile; Olivia Geraci; Ansley Gnanapragasam; Elias Gomah; Elie Haber; Claudia Hamel; Thivya Iyanker; Christina Kalantzis; Sara Kamali; Elsa Kassardjian; Hryssi Krissy Kontos; Thi Bich Uyen Le; Daniella LoScerbo; Yan Fang Low; Danielle Mac Rae; Flore Maurer; Sana Mazhar; Alice Nguyen; Kathy Nguyen-Duong; Chelsea Osborne-Laroche; Hwi Wun Park; Emilie Parolin; Kahlila Paul-Cole; Leah Sarah Peer; Margaux Philippon; Charles-Alexandre Plaisir; Jessica Porras Marroquin; Simran Prasad; Rewaparsad Ramsarun; Saad Razzaq; Samantha Rhainds; Damien Robin; Ryan Scartozzi; Davindra Singh; Sajad Soleimani Fard; Maxim Soroko; Nastaran Soroori Motlagh; Kiri Stern; Laila Toro; M Wyatt Toure; Stephanie Tran-Huynh; Sarah Trépanier-Chicoine; Claudia Waddingham; Aaliyah Jasmine Weekes; Allison Wisniewski; Chiara Gamberi
Journal:  Biomedicines       Date:  2021-01-18

5.  The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study.

Authors:  Cihan Atila; Sophie Monnerat; Sandrine Andrea Urwyler; Julie Refardt; Bettina Winzeler; Mirjam Christ-Crain
Journal:  Pituitary       Date:  2022-06-20       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.